Zydus Beats Gilead, Ipsen On Cholangitis Primary Endpoint But Pruritus Data Is Key

 
• By Vibha Ravi
  
Primary Biliary Cholangitis or Cirrhosis, PBC
Zydus Has Encouraging Results From Its PBC Drug Candidate Saroglitazar (Shutterstock)

More from Clinical Trials

More from R&D